Literature DB >> 27527619

Therapeutic Approaches Using Riboflavin in Mitochondrial Energy Metabolism Disorders.

Bárbara J Henriques, Tânia G Lucas, Cláudio M Gomes1.   

Abstract

Riboflavin, or vitamin B2, plays an important role in the cell as biological precursor of FAD and FMN, two important flavin cofactors which are essential for the structure and function of flavoproteins. Riboflavin has been used in therapeutic approaches of various inborn errors of metabolism, notably in metabolic disorders resulting either from defects in proteins involved in riboflavin metabolism and transport or from defects in flavoenzymes. The scope of this review is to provide an updated perspective of clinical cases in which riboflavin was used as a potential therapeutic agent in disorders affecting mitochondrial energy metabolism. In particular, we discuss available mechanistic insights on the role of riboflavin as a pharmacological chaperone for the recovery of misfolded metabolic flavoenzymes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27527619     DOI: 10.2174/1389450117666160813180812

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  8 in total

1.  Novel SLC25A32 mutation in a patient with a severe neuromuscular phenotype.

Authors:  Debby M E I Hellebrekers; Suzanne C E H Sallevelt; Tom E J Theunissen; Alexandra T M Hendrickx; Ralph W Gottschalk; Janneke G J Hoeijmakers; Daphna D Habets; Jörgen Bierau; Kees G Schoonderwoerd; Hubert J M Smeets
Journal:  Eur J Hum Genet       Date:  2017-04-26       Impact factor: 4.246

Review 2.  Electron transfer flavoprotein and its role in mitochondrial energy metabolism in health and disease.

Authors:  Bárbara J Henriques; Rikke Katrine Jentoft Olsen; Cláudio M Gomes; Peter Bross
Journal:  Gene       Date:  2021-01-13       Impact factor: 3.688

Review 3.  Mitochondrial Agents for Bipolar Disorder.

Authors:  Círia Pereira; Victor Chavarria; João Vian; Melanie Maree Ashton; Michael Berk; Wolfgang Marx; Olivia May Dean
Journal:  Int J Neuropsychopharmacol       Date:  2018-06-01       Impact factor: 5.176

4.  E-Learning for Rare Diseases: An Example Using Fabry Disease.

Authors:  Chiara Cimmaruta; Ludovica Liguori; Maria Monticelli; Giuseppina Andreotti; Valentina Citro
Journal:  Int J Mol Sci       Date:  2017-09-24       Impact factor: 5.923

5.  Urinary Metabolomic Profiling Analysis and Evaluation of the Effect of Ecklonia cava Extract Intake.

Authors:  Juyeon Kim; Youngae Jung; Eunok Lee; Seoyeong Jang; Do Hyun Ryu; Oran Kwon; Geum-Sook Hwang
Journal:  Nutrients       Date:  2020-05-14       Impact factor: 5.717

6.  Pterostilbene in Combination With Mitochondrial Cofactors Improve Mitochondrial Function in Cellular Models of Mitochondrial Diseases.

Authors:  Juan M Suárez-Rivero; Carmen J Pastor-Maldonado; Ana Romero-González; David Gómez-Fernandez; Suleva Povea-Cabello; Mónica Álvarez-Córdoba; Irene Villalón-García; Marta Talaverón-Rey; Alejandra Suárez-Carrillo; Manuel Munuera-Cabeza; José A Sánchez-Alcázar
Journal:  Front Pharmacol       Date:  2022-03-18       Impact factor: 5.810

7.  Cell metabolomics to study the function mechanism of Cyperus rotundus L. on triple-negative breast cancer cells.

Authors:  Shuangshuang Ma; Fukai Wang; Caijuan Zhang; Xinzhao Wang; Xueyong Wang; Zhiyong Yu
Journal:  BMC Complement Med Ther       Date:  2020-08-26

8.  Functional Recovery of a GCDH Variant Associated to Severe Deflavinylation-Molecular Insights into Potential Beneficial Effects of Riboflavin Supplementation in Glutaric Aciduria-Type I Patients.

Authors:  Joana V Ribeiro; Cláudio M Gomes; Bárbara J Henriques
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.